.Exelixis is giving up on its cells variable (TF)- targeting antibody-drug conjugate after concludin...
.3 full weeks after Roche's Genentech device walked away from an SHP2 prevention deal, Relay Rehab h...
.Stoke Therapies' Dravet disorder medicine has been devoid of a partial hold, removing the method fo...
.Tough Biotech Partner Publisher Gabrielle Masson provided the 2024 course of Tough 15 victors on th...
.Merck & Co. has actually quickly recovered some of the prices of its Weapon Therapeutics buyout,...
.After BioMarin performed a springtime clean of its own pipeline in April, the business has decided ...
.Large Pharmas remain stuck to the concept of molecular adhesive degraders. The latest company to vi...
.A brand new worldwide life science credit scores firm, called Symbiotic Funds, has actually reared ...
.Bristol Myers Squibb is actually axing yet another major bet from the Caforio period, ending a pack...
.After taking a look at period 1 data, Nuvation Bio has actually decided to stop deal with its singl...